| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099455 | Journal of Crohn's and Colitis | 2013 | 4 Pages |
Abstract
One year infliximab administration is associated with a long term benefit in patients with chronic refractory pouchitis following IPAA for UC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Nikos Viazis, Marios Giakoumis, Theodoros Koukouratos, Jiannis Anastasiou, Konstantina Katopodi, Georgios Kechagias, Elias Anastasopoulos, Efstathios Saprikis, Michail Chanias, George Tribonias, Dimitrios G. Karamanolis,